Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible Light Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106831603A reveals a visible-light promoted, transition-metal-free synthesis of perfluoroalkylpyrimidines, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN107417615A enables high-purity quinolinone manufacturing via visible light catalysis. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN108727246B details a metal-free visible light method for indole C3 alkylation using organic dyes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112812060B reveals a metal-free, visible-light driven arylation method for tetrahydroquinoline derivatives, offering green synthesis routes for pharmaceutical intermediates.
Patent CN111333526B reveals a green photoredox method for N-aryl glycine esters. Discover cost-effective, scalable synthesis for pharmaceutical intermediates.
Novel visible-light mediated method for 1,1-diarylalkanes. High yield, mild conditions. Ideal for pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN114213312B details photocatalyst-free visible light synthesis for 3-selenocyanoindole intermediates ensuring cost reduction and supply chain reliability for global buyers.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN114213254B details a visible-light mediated synthesis of beta-nitroketones. Offers high yield, mild conditions, and scalable routes for pharmaceutical intermediates.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Patent CN110540516B details a novel photocatalytic route for dihydronaphthalene derivatives, offering mild conditions and high yields for pharmaceutical manufacturing.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Solve piperazine cyanation challenges with metal-free visible light catalysis. 83% yield, air atmosphere, no expensive equipment. Scale to 100MT/yr.
Solve heavy metal contamination in benzothiazole synthesis. Our CDMO expertise scales this visible light method with >99% purity and 98% yield for your API production.
Discover how visible light catalysis enables 90% yield 3-alkylquinoxaline-2(1H)-ketone synthesis at room temperature, reducing production costs and safety risks for pharmaceutical intermediates.
Eliminate expensive catalysts and harsh conditions in aryltrimethylstannane production. 95% yields, metal-free process, and scalable manufacturing for pharmaceutical intermediates.
Eliminate transition metal costs and harsh conditions. Our CDMO expertise scales this visible light method for 90%+ yields in 3-selenofuran production. Request COA/MSDS now.
Solve arylstannane synthesis challenges with 95% yields, no metal catalysts, and room-temperature processing. Reduce costs and supply chain risks for pharmaceutical intermediates.
Discover how metal-free visible light catalysis enables high-yield, enantioselective synthesis of chiral alpha-azaarene compounds for drug development. Reduce production costs and supply chain risks.